Skip to main content
Livermore
Livermore
ZHEN

Avadel Pharmaceuticals PLC

AVDLDelisted Feb 12, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001012477

Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Avadel Pharmaceuticals PLC as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
101
+8 vs. Q1 2023
Shares held
52.0M
+3.52M (+7.3%) vs. Q1 2023
Total value
$856.2M
+$413.1M (+93.2%) vs. Q1 2023
New holders
25
34 more added
Sold out
17
24 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AVDL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 101 institutions
Q1 2021: 77 institutionsQ2 2021: 80 institutionsQ3 2021: 82 institutionsQ4 2021: 85 institutionsQ1 2022: 81 institutionsQ2 2022: 82 institutionsQ3 2022: 76 institutionsQ4 2022: 83 institutionsQ1 2023: 93 institutionsQ2 2023: 101 institutionsQ3 2023: 99 institutionsQ4 2023: 113 institutionsQ1 2024: 126 institutionsQ2 2024: 156 institutionsQ3 2024: 176 institutionsQ4 2024: 160 institutionsQ1 2025: 177 institutionsQ2 2025: 174 institutionsQ3 2025: 188 institutionsQ4 2025: 208 institutionsQ1 2026: 2 institutionsQ2 2026: 1 institution
Value heldQ2 2023: $856.2M
Q1 2021: $294.4MQ2 2021: $219.1MQ3 2021: $314.2MQ4 2021: $287.0MQ1 2022: $244.5MQ2 2022: $82.3MQ3 2022: $157.2MQ4 2022: $239.5MQ1 2023: $443.2MQ2 2023: $856.2MQ3 2023: $559.4MQ4 2023: $795.3MQ1 2024: $1.18BQ2 2024: $1.04BQ3 2024: $979.2MQ4 2024: $837.4MQ1 2025: $613.0MQ2 2025: $721.2MQ3 2025: $1.22BQ4 2025: $1.60BQ1 2026: $442Q2 2026: $16
Institutions holding AVDL and their total value by quarter
QuarterHoldersValue
Q2 20261$16
Q1 20262$442
Q4 2025208$1.60B
Q3 2025188$1.22B
Q2 2025174$721.2M
Q1 2025177$613.0M
Q4 2024160$837.4M
Q3 2024176$979.2M
Q2 2024156$1.04B
Q1 2024126$1.18B
Q4 2023113$795.3M
Q3 202399$559.4M
Q2 2023101$856.2M
Q1 202393$443.2M
Q4 202283$239.5M
Q3 202276$157.2M
Q2 202282$82.3M
Q1 202281$244.5M
Q4 202185$287.0M
Q3 202182$314.2M
Q2 202180$219.1M
Q1 202177$294.4M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Avadel Pharmaceuticals PLC; share changes are against Q1 2023.

Institutions holding AVDL in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Janus Henderson Group PLC7,522,545$124.0M0.08%+695,758+10.2%Added
Perceptive Advisors LLC0$00.00%−590,000−100.0%Sold out
Altium Capital Management LP0$00.00%−500,000−100.0%Sold out
Maven Securities LTD0$00.00%−450,000−100.0%Sold out
Millennium Management LLC0$00.00%−288,910−100.0%Sold out
Monashee Investment Management LLC0$00.00%−275,000−100.0%Sold out
Trexquant Investment LP0$00.00%−42,435−100.0%Sold out
Virtu Financial LLC0$00.00%−16,759−100.0%Sold out
National Asset Management, Inc.0$00.00%−15,000−100.0%Sold out
Legacy Wealth Asset Management, LLC0$00.00%−13,000−100.0%Sold out
Lazard Asset Management LLC0$00.00%−12,166−100.0%Sold out
Sawtooth Solutions, LLC0$00.00%−10,000−100.0%Sold out
Caas Capital Management LP0$00.00%−10,000−100.0%Sold out
Signaturefd, LLC0$00.00%−2,050−100.0%Sold out
Journey Strategic Wealth LLC0$00.00%−10,000−100.0%Sold out
WR Wealth Planners, LLC0$00.00%−468−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−128−100.0%Sold out
Ameritas Advisory Services, LLC0$00.00%−100−100.0%Sold out